Evidence map›Paper›PMID 29325618›Full record

ReviewHandbook of clinical neurology2018

Neurodegeneration with brain iron accumulation.

Susan J Hayflick, Manju A Kurian, Penelope Hogarth

Abstract readReview
In one paragraph

Review in Handbook of clinical neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase-Associated Neurodegeneration.Movement disorders : official journal of the Movement Disorder Society · 2021
    Trial
  3. Article
  4. Article
  5. Supplementation via DAF-16 andbioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Very late-onset MPAN presenting with rapid cognitive deterioration.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Review

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Susan J HayflickDepartments of Molecular and Medical Genetics, Pediatrics and Neurology, Oregon Health and Science University, Portland, OR, United States. Electronic address: hayflick@ohsu.edu.
Manju A KurianMolecular Neurosciences, Developmental Neurosciences Programme, Institute of Child Health, University College London and Department of Neurology, Great Ormond Street Hospital, London, United Kingdom.
Penelope HogarthDepartments of Molecular and Medical Genetics and Neurology, Oregon Health and Science University, Portland, OR, United States.

Funding

PKAN pathogenesis and treatmentR01NS109083 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI HAYFLICK, SUSAN J · 2018 to 2020
$1.0M
Department of Health RP-2016-07-019NINDS NIH HHS R01 NS109083
6 · The paper itself

Abstract

Neurodegeneration with brain iron accumulation (NBIA) comprises a clinically and genetically heterogeneous group of disorders affecting children and adults. These rare disorders are often first suspected when increased basal ganglia iron is observed on brain magnetic resonance imaging. For the majority of NBIA disorders the genetic basis has been delineated, and clinical testing is available. The four most common NBIA disorders include pantothenate kinase-associated neurodegeneration (PKAN) due to mutations in PANK2, phospholipase A

Indexed as

BrainCarrier ProteinsGroup VI Phospholipases A2HumansIronIron Metabolism DisordersMitochondrial ProteinsMutationNeurodegenerative DiseasesPhosphotransferases (Alcohol Group Acceptor)C19orf12 protein, humanCarrier ProteinsGroup VI Phospholipases A2IronMitochondrial Proteinspantothenate kinasePhosphotransferases (Alcohol Group Acceptor)PLA2G6 protein, humanWDR45 protein, humanBPANINADinfantile neuroaxonal dystrophyMPANNBIAneurodegeneration with brain iron accumulationpantothenate kinasePKANPLAN

Identifiers

PMID29325618
PMCPMC8235601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.